Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Search Results (371)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Ratain, Mark J.Person Why?
O'Donnell, Peter H.Person Why?
Dolan, Mary EileenPerson Why?
EGFR pharmacogenomics: the story continues to mutate and evolve.Academic Article Why?
From personalized medicine to personalized justice: the promises of translational pharmacogenomics in the justice system.Academic Article Why?
Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing.Academic Article Why?
Genome-wide approaches in pharmacogenomics: heritability estimation and pharmacoethnicity as primary challenges.Academic Article Why?
Genomewide Association Studies in Pharmacogenomics: Meeting Report of the NIH Pharmacogenomics Research Network-RIKEN (PGRN-RIKEN) Collaboration.Academic Article Why?
Lymphoblastoid cell lines in pharmacogenomics: how applicable are they to clinical outcomes?Academic Article Why?
Patient perspectives following pharmacogenomics results disclosure in an integrated health system.Academic Article Why?
Pharmacogenetics and pharmacogenomics: a bridge to individualized cancer therapy.Academic Article Why?
Pharmacogenomics and cardiology: improving treatment with existing drugs.Academic Article Why?
Pharmacogenomics and personalized medicine in clinical practice.Academic Article Why?
[SNP collection, pharmacogenomics, and the future of drug therapy].Academic Article Why?
A Physiologic Approach to the Pharmacogenomics of Hypertension.Academic Article Why?
Per Page    Page  of 25last Nextnext
Prev
Search Criteria
  • Pharmacogenomics
Filter by Type